Skip to main content
Download PDF
Download ePub

Effects of passive smoking on cortical spreading depolarization in male and female mice

The Journal of Headache and Pain volume 25, Article number: 162 (2024) Cite this article

Abstract

Background

Patients with migraine are typically advised to avoid passive smoking because it may aggravate headaches and other health conditions. However, there is insufficient high-quality evidence on the association between passive smoking and migraine, which warrants further investigation using animal models. Therefore, using a mouse model, we examined the effect of passive smoking on susceptibility to cortical spreading depolarization (CSD), the biological basis of migraine with aura.

Findings

Fifty C57BL/6 mice (25 males and 25 females) were exposed for one hour to cigarette smoke or room air. Subsequently, potassium chloride (KCl) was administered under isoflurane anesthesia to induce CSD, and the CSD threshold, frequency of induction, and propagation velocity were determined. The threshold to induce CSD (median [interquartile range (IQR)]) was significantly lower in female mice (adjusted p = 0.01) in the smoking group (0.05 [0.05, 0.088]) than in the sham group (0.125 [0.1, 0.15]); however, there was no significant difference in the male mice (adjusted p = 0.77). CSD frequency or propagation velocity did not differ significantly between the two groups for either sex.

Conclusions

Female mice in the smoking group showed lower CSD threshold compared to the sham group, suggesting a potential sex-specific difference in the effect of smoking on the pathogenesis of CSD and migraine with aura. This finding may contribute to the understanding of migraine pathophysiology in association with passive smoking and sex difference.

Peer Review reports

Introduction

Migraine, a significant public health problem that affects over 1 billion people worldwide [1, 2], ranks as the second leading cause of years of life lived with disability [3, 4]. Despite advancements in migraine medication, including anti-calcitonin gene-related peptide monoclonal antibodies (anti-CGRP mAbs) and gepants, only about 10% of patients can achieve complete control of attack frequency with drug therapy [5]. Therefore, physicians educate patients to adopt lifestyle modifications such as appropriate sleep, exercise, reduced alcohol intake, and avoiding passive smoking to manage migraine symptoms effectively.

Despite many studies reporting potential relationships between smoking and migraine onset [6] and recent reports linking secondhand smoke exposure to headaches and migraine in the nonsmoking population [7], the absence of high-quality evidence in humans prevents a consensus from developing regarding the existence of a causal relationship between migraine and passive smoking [6]. Given the established risks of smoking to humans, including increased risks of cancer and cardiovascular events [8], it is considered unethical to investigate the effect of smoking on migraine using human participants. Therefore, investigating the association between migraine and smoking through animal models of migraine might enhance our understanding of migraine pathophysiology.

Cortical spreading depolarization (CSD) is an established rodent model used to study migraine, especially migraine with aura. CSD is caused by the depolarization of neurons and glial cells, propagates through the cortex, and is a biological event occurring during the aura phase of migraine [9, 10]. Prior research has demonstrated that CSD was exacerbated by migraine-inducing or aggravating factors, including stress, and was suppressed by migraine prophylaxis [9, 11, 12].

We aimed to capture the potential effect of passive smoking on migraine with aura in an in vivo migraine model of CSD, considering the advantages of objective measurements in CSD.

Methods

Ethics

All experimental procedures were approved by the Keio University Institutional Animal Care and Use Committee (authorizations A2021-006 and A2022-257). All procedures were performed in accordance with university guidelines and Animal Research: Reporting of In Vivo Experiments (ARRIVE) reporting guidelines for the care and use of laboratory animals.

Animals

Fifty C57BL/6 mice (25 males and 25 females, 8 weeks old) were purchased from CLEA Japan Inc. (Tokyo, Japan). They were housed for acclimatization under a 12-h dark–light cycle in an air-conditioned room (temperature of 23.0 °C ± 1.0 °C and humidity of 55% ± 7%) with unrestricted access to water and food for > 1 week before conducting the following experiments.

Of the 25 male and 25 female mice, the following animals were excluded from the analysis: Male mice, 2 due to death during exposure to cigarette smoke and 1 due to insufficient sample volume for blood gas analysis in the smoking group, 2 due to poor blood gas, and 1 due to a failure of femoral artery catheterization in the sham group; female mice: 2 due to death during smoke exposure, 1 due to poor blood gas, and 1 due to insufficient sample volume for blood gas analysis in the smoking group, 3 due to poor blood gas, 1 due to insufficient sample volume for blood gas analysis, and 1 due to ear bleeding in the sham group. Thus, 7–10 mice from each group (male-smoking, male-sham, female-smoking, and female-sham) were analyzed.

Cigarette smoke exposure procedure

The mice were randomly assigned to either smoking or sham groups. Mice in the smoking group were restrained in an immobilization tube and exposed to cigarette smoke from commercially available filtered cigarettes (Marlboro, 12 mg tar/1.0 mg nicotine, Philip Morris, Richmond, VA) through nasal inhalation for 1 h, as previously reported. Following dilution with compressed air, the mass concentration of total particulate matter was 1,202 ± 196 mg/m3 [13]. Mice in the sham group were restrained in the same setting as the smoking group for immobilization and exposed to room air. One hour was allowed for recovery after exposure to cigarette smoke or room air so that the physiological state could remain unchanged during the recordings.

CSD evaluation

The following parameters were recorded: direct current (DC) potential, regional cerebral blood flow (rCBF), systemic arterial blood pressure (ABP), and heart rate (HR). The rectal temperature was maintained at 37 °C with a heating pad and thermocontroller (BWT-100, Bio Research Center Co. Ltd., Nagoya, Japan) as described previously [14] (Fig. 1-(a), (b)). In brief, one hour after smoking or being restrained, a catheter was inserted into the femoral artery to monitor blood pressure under isoflurane anesthesia (2%–2.3%). The mouse was secured to a head-holder (SGM-4, Narishige Scientific Instrument Laboratory, Tokyo, Japan). Prior to CSD evaluation, arterial blood was drawn through the catheter for blood gas analysis with RapidLab 348EX (Siemens AG., Munich, Germany). DC potentials were monitored using three electrodes (EEG-5002Ag; tip diameter = 200 µm; Bio Research Center) that were fixed in the bilateral parietal (± 2 mm lateral and 2 mm caudal to the bregma) and right frontal (2 mm lateral and 1 mm rostral to the bregma) openings in the skull. Over the parietal bone, rCBF was monitored bilaterally using laser Doppler flowmeters (ALF21, Advance Co. Ltd., Tokyo, Japan). Continuous recordings of DC potential, rCBF, ABP, and HR were stored on a multichannel recorder (PowerLab 8/35; ADInstruments Pty Ltd., Sydney, Australia). The LabChart software (ADInstruments Pty Ltd.) was used for offline analysis (Fig. 1-(b)). We considered it a CSD occurrence when we observed unilateral CBF changes that were characteristic of CSD and were synchronized with the deflection of DC potentials. DC potentials were recorded with monopolar electrodes, with a reference electrode placed subcutaneously in the dorsum.

Fig. 1
figure 1

a Experimental protocol and CSD setup. Fifty C57BL/6 mice (25 males and 25 females) were divided either into the smoking group to receive cigarette smoke exposure for one hour (1 h) or the sham group to receive room air for 1 h in a tube for immobilization. After 1 h of recovery, followed by preparation, the minimum KCl concentration to evoke CSD (threshold of CSD induction) and frequency of CSD induced by a 1 M KCl cotton ball were measured in 1 h. The propagation velocity was calculated from the time differences and distances between two direct current (DC) electrodes. b Representative raw tracing of recorded CSD. DC, direct current; rCBF, regional cerebral blood flow

Full size image

After reducing the isoflurane concentration to 1.5% and confirming that no CSD occurred for a duration exceeding 30 min, 5 µL of 0.025 M potassium chloride (KCl) solution was introduced into the left posterior hole; the KCl concentration was increased in a stepwise manner by 0.025 M at intervals of at least 5 min. The concentration at which CSD first manifested was designated as the threshold for CSD [14, 15]. CSD induction was validated by the presence of characteristic DC potential deflection and unilateral rCBF fluctuation. The frequency of CSD induced in the right hemisphere was assessed by calculating the number of CSD events that occurred within a 60-min period. The 1-M KCl cotton ball was replaced every 15 min. The propagation velocity of the first-manifested CSD was calculated using the distance and time difference between the two electrodes. CSD measurement was performed in part by a blinded investigator.

Statistics

We analyzed the threshold to induce CSD, the frequency of CSD at 1 M KCl, and the propagation velocity of CSD (Fig. 1). Animals that were deceased or exhibited poor physiological status, or in which technical errors occurred during the procedure were excluded. In general, we used the Wilcoxon rank sum test. The Wilcoxon rank sum test with Bonferroni correction was used for the statistical analysis of the effect on the CSD threshold. Statistical analysis was performed using the SAS version 9.4 software (SAS Institute, Cary, NC), and graphs were created using the Prism version 9.2.0 software (GraphPad Software, La Jolla, CA).

Results

In the female mice, the median [interquartile range (IQR)] of the induction threshold was significantly lower in the smoking group (0.05 [0.05, 0.088]) than in the sham group (0.125 [0.1, 0.15]) (adjusted p = 0.01). Overall, other measurements yielded nonsignificant results. The median threshold of CSD in male mice was 0.075 [0.063, 0.125] in the smoking group and 0.125 [0.069, 0.156] in the sham group (adjusted p = 0.77) (Fig. 2). The adjusted p-value between the male and female mice in the smoking group was 0.46. There were no significant differences in the frequency of CSD induction or the propagation velocity between smoking and sham groups in both male and female mice (Fig. 2).

Fig. 2
figure 2

a Threshold, b Frequency, and c Propagation velocity of CSD between the smoking and sham groups in male and female mice. Whiskers represent the complete range; boxes represent the interquartile range; horizontal lines represent the median; and + represents the mean. Individual data points from each animal are also shown

Full size image

In the arterial blood analysis, pH was higher (p = 0.03, 0.03 in males and females, respectively), and [Na+] was lower (p = 0.02, p < 0.01 in males and females, respectively) in the smoking group. In the male mice, [HCO3−] and [K+] were higher in the smoking group (p < 0.01, p = 0.03). In the female mice, mean arterial blood pressure (MABP) was lower in the smoking group (p < 0.01), as shown in Table 1.

Table 1 Comparison of physiological parameters between the smoking and sham groups
Full size table

Discussion

In this study, the median CSD threshold in female mice in the smoking group was significantly lower than that in the sham group. Cigarette smoke exposure might have predisposed the female mice to CSD, a biological event that occurs during the aura phase of a migraine and is thought to be involved in the pathogenesis of migraine with aura [16]. This sex difference could be discussed both in terms of sex difference in migraine pathophysiology and cigarette smoke susceptibility.

First, previous observational human studies have controversially linked cigarette smoking to migraine onset and triggers. A Danish population-based cross-sectional study on 31,865 twin individuals found that both women and men with a smoking history demonstrated increased risks for both migraine with aura and migraine without aura [17]. Norwegian large-scale population-based cross-sectional studies revealed that smokers were more likely to have migraine [18, 19], but did not elucidate the relevant data regarding aura and sexes. A prospective study of 54 patients revealed that the greatest risk factor for the occurrence of aura is smoking; however, smoking decreased the risk of headache or migraine without aura [20]. Regarding differences between sexes, a survey of 361 Spanish medical students revealed that the prevalence of active smoking is one-third higher in students with migraine. A clearer relationship between migraine and smoking was observed in females, partly owing to the lesser number of males among both medical students and smokers [21]. Additionally, a retrospective study on 494 patients with migraine in the US revealed that 26% of them cited cigarette smoke as a trigger factor, with the proportion of females (29%) being significantly higher compared to males (13%) [22]. The difference related to aura was not clarified in either of these two studies. Moreover, a literature review revealed inconclusive results regarding the association between smoking and headaches [6]. These conflicting findings warrant further investigation to fully understand the association between migraine and smoking in both humans and animals.

Second, susceptibility to cigarette smoke in the respiratory system has been considered sex-dependent and often more severe in females, both in mice [23] and human [24, 25]. The assumably greater injury of the respiratory systems by cigarette smoke might have predisposed female mice brain to be affected to a greater extent in our study.

Previous evidence regarding cigarette smoke can be utilized to analyze the potential mechanisms underlying the decreased threshold of CSD in this study. Cigarette smoke contains more than 4,700 chemicals, with varying percentages among different cigarette types [6]. Specifically, nicotine and carbon monoxide (CO) are recognized to affect the nervous system. For example, stimulation of nicotinic receptors increases the sensitivity of the chicken retina to retinal spreading depolarization [26]. This may be similar to the mechanism of the CSD sensitivity change induced by smoking in this study. Another study exhibited that CO exposure influences the frequency of CSD in rat brains; however, the impact of CO on CSD frequency varied depending on the time after exposure [27]. For instance, CSD frequency decreased immediately after CO exposure but increased 90 min later. Notably, the study was conducted exclusively on male rats; therefore, sex and species differences must be considered when interpreting the results.

Interestingly, in contrast to a previous study that showed a significantly reduced threshold for induction of CSD in female mice compared to male mice [28], our results did not show any significant difference between females and males in CSD threshold in the sham group. This discrepancy may be due to the differences in experimental setups, and further studies with larger sample sizes would be necessary to conclude this topic.

Regarding blood gas analysis and MABP, we observed several significant differences between the two groups. The smoking group exhibited elevated pH levels and decreased [Na+] in both sexes. Elevated pH may have potentially affected CSD parameters; since NMDA receptors are inhibited by extracellular protons [29], increased pH may have possibly decreased the tonic proton block and increased cortical excitability. Hyponatremia is associated with increased cortical excitability [30] and may also have affected CSD parameters. Only male mice in the smoking group had elevated [K+] and [HCO3−] concentrations. Female mice exhibited lower MABP in the smoking group. MABP was previously shown to be negatively correlated with CSD durations [31], but we did not observe a significant change in CSD duration. Currently, there is no established evidence of the association between blood gas analysis or MABP and the threshold of CSD [32]. Therefore, we cannot determine whether these factors influenced the changes in CSD threshold in female mice. Further research is required to examine the correlations.

The study has a few limitations. The acute effects of smoking on CSD were investigated in this study; therefore, the discussion may not be applicable to the chronic effects of smoking. Because exposure to smoking was conducted in only one condition, the dose–effect relationship of smoking could not be determined. Another limitation is that the natural estrous cycle could have contaminated our results; a previous study showed that the CSD threshold was significantly reduced during the diestrus period [33]. However, this possible effect of the estrous cycle on our results was minimized in our randomized controlled study design using 7–9 mice per group. Moreover, to conclude our question, additional quantitative data and mechanism studies are necessary. Lastly, as CSD is an animal model of migraine with aura, the results cannot be directly extrapolated to migraine without aura.

Conclusion

Female mice in the smoking group showed lower CSD threshold compared to the sham group. We suggest that there may be sex-based differences in the impact of smoking on migraine via a stronger predisposition to CSD in female mice. Additional research is needed to verify if smoking cessation could be beneficial in preventing or managing migraine.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.

Abbreviations

CSD:

Cortical spreading depolarization

KCl:

Potassium chloride

CO:

Carbon monoxide

MABP:

Mean arterial blood pressure

ABP:

Arterial blood pressure

DC:

Direct current

rCBF:

Regional cerebral blood flow

HR:

Heart rate

References

  1. Ashina M, Katsarava Z, Do TP et al (2021) Migraine: epidemiology and systems of care. Lancet 397(10283):1485–1495

    Article  PubMed  Google Scholar 

  2. Yuan S, Daghlas I, Larsson SC (2022) Alcohol, coffee consumption, and smoking in relation to migraine: a bidirectional Mendelian randomization study. Pain 163(2):e342–e348

    Article  PubMed  Google Scholar 

  3. Collaborators GBDH (2018) Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17(11):954–976

    Article  Google Scholar 

  4. Waliszewska-Prosol M, Montisano DA, Antolak M et al (2024) The impact of primary headaches on disability outcomes: a literature review and meta-analysis to inform future iterations of the Global Burden of Disease study. J Headache Pain 25(1):27

    Article  PubMed  PubMed Central  Google Scholar 

  5. Takizawa T, Ohtani S, Watanabe N et al (2022) Real-world evidence of galcanezumab for migraine treatment in Japan: a retrospective analysis. BMC Neurol 22(1):512

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Taylor FR (2015) Tobacco, Nicotine, and Headache. Headache 55(7):1028–44

    Article  PubMed  Google Scholar 

  7. Wu J, Yang P, Wu X et al (2023) Association between secondhand smoke exposure and severe headaches or migraine in never-smoking adults. Headache 63(10):1341–1350

    Article  PubMed  Google Scholar 

  8. Dai X, Gil GF, Reitsma MB et al (2022) Health effects associated with smoking: a Burden of Proof study. Nat Med 28(10):2045–2055

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Kramer DR, Fujii T, Ohiorhenuan I et al (2016) Cortical spreading depolarization: Pathophysiology, implications, and future directions. J Clin Neurosci 24:22–27

    Article  PubMed  Google Scholar 

  10. Takizawa T, Ayata C, Chen SP (2020) Therapeutic implications of cortical spreading depression models in migraine. Prog Brain Res 255:29–67

    Article  PubMed  Google Scholar 

  11. Liu TT, Morais A, Takizawa T et al (2022) Efficacy profile of noninvasive vagus nerve stimulation on cortical spreading depression susceptibility and the tissue response in a rat model. J Headache Pain 23(1):12

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Ayata C, Jin H, Kudo C et al (2006) Suppression of cortical spreading depression in migraine prophylaxis. Ann Neurol 59(4):652–661

    Article  CAS  PubMed  Google Scholar 

  13. Sasaki M, Chubachi S, Kameyama N et al (2015) Evaluation of cigarette smoke-induced emphysema in mice using quantitative micro-computed tomography. Am J Physiol Lung Cell Mol Physiol 308(10):L1039–L1045

    Article  PubMed  Google Scholar 

  14. Iba C, Unekawa M, Izawa Y et al (2022) Effect of Goreisan, a Japanese Traditional Medicine, on Cortical Spreading Depolarization in Mice. Int J Mol Sci 23(22):13803

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Unekawa M, Ikeda K, Tomita Y et al (2018) Enhanced susceptibility to cortical spreading depression in two types of Na(+), K(+)-ATPase α2 subunit-deficient mice as a model of familial hemiplegic migraine 2. Cephalalgia 38(9):1515–1524

    Article  PubMed  Google Scholar 

  16. Hadjikhani N, Sanchez Del Rio M, Wu O et al (2001) Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A 98(8):4687–4692

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Le H, Tfelt-Hansen P, Skytthe A et al (2011) Association between migraine, lifestyle and socioeconomic factors: a population-based cross-sectional study. J Headache Pain 12(2):157–172

    Article  PubMed  PubMed Central  Google Scholar 

  18. Hagen K, Asberg AN, Stovner L et al (2018) Lifestyle factors and risk of migraine and tension-type headache. Follow-up data from the Nord-Trondelag Health Surveys 1995–1997 and 2006–2008. Cephalalgia 38(13):1919–1926

    Article  PubMed  Google Scholar 

  19. Aamodt AH, Stovner LJ, Hagen K et al (2006) Headache prevalence related to smoking and alcohol use. The Head-HUNT Study. Eur J Neurol 13(11):1233–1238

    Article  CAS  PubMed  Google Scholar 

  20. Salhofer-Polanyi S, Frantal S, Brannath W et al (2012) Prospective analysis of factors related to migraine aura–the PAMINA study. Headache 52(8):1236–1245

    Article  PubMed  Google Scholar 

  21. Lopez-Mesonero L, Marquez S, Parra P et al (2009) Smoking as a precipitating factor for migraine: a survey in medical students. J Headache Pain 10(2):101–103

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Robbins L (1994) Precipitating factors in migraine: a retrospective review of 494 patients. Headache 34(4):214–216

    Article  CAS  PubMed  Google Scholar 

  23. Ghosh B, Chengala PP, Shah S et al (2023) Cigarette smoke-induced injury induces distinct sex-specific transcriptional signatures in mice tracheal epithelial cells. Am J Physiol Lung Cell Mol Physiol 325(4):L467–L476

    Article  CAS  PubMed  Google Scholar 

  24. Kirkpatrick d P, Dransfield MT (2009) Racial and sex differences in chronic obstructive pulmonary disease susceptibility, diagnosis, and treatment. Curr Opin Pulm Med 15(2):100–4

    Article  PubMed  Google Scholar 

  25. Kokturk N, Kilic H, Baha A et al (2016) Sex Difference in Chronic Obstructive Lung Disease. Does it Matter? A Concise Review. COPD 13(6):799–806

    Article  PubMed  Google Scholar 

  26. Sheardown MJ (1997) The triggering of spreading depression in the chick retina by nicotinic receptor agonists. Eur J Pharmacol 337(2–3):209–212

    Article  CAS  PubMed  Google Scholar 

  27. Meilin S, Sonn J, Zarchin N et al (1998) Responses of rat brain to induced spreading depression following exposure to carbon monoxide. Brain Res 780(2):323–328

    Article  CAS  PubMed  Google Scholar 

  28. Brennan KC, Romero Reyes M, Lopez Valdes HE et al (2007) Reduced threshold for cortical spreading depression in female mice. Ann Neurol 61(6):603–606

    Article  PubMed  Google Scholar 

  29. Traynelis SF, Hartley M, Heinemann SF (1995) Control of proton sensitivity of the NMDA receptor by RNA splicing and polyamines. Science 268(5212):873–876

    Article  CAS  PubMed  Google Scholar 

  30. Lauderdale K, Murphy T, Tung T et al (2015) Osmotic Edema Rapidly Increases Neuronal Excitability Through Activation of NMDA Receptor-Dependent Slow Inward Currents in Juvenile and Adult Hippocampus. ASN Neuro 7(5):1759091415605115

    Article  PubMed  PubMed Central  Google Scholar 

  31. Shukla G, Parks K, Smith DW et al (2023) Impact of Hypo- and Hyper-capnia on Spreading Depolarizations in Rat Cerebral Cortex. Neuroscience 15(530):46–55

    Article  Google Scholar 

  32. Ayata C (2013) Pearls and pitfalls in experimental models of spreading depression. Cephalalgia 33(8):604–613

    Article  PubMed  Google Scholar 

  33. Ebine T, Toriumi H, Shimizu T et al (2016) Alterations in the threshold of the potassium concentration to evoke cortical spreading depression during the natural estrous cycle in mice. Neurosci Res 112:57–62

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Akira Saito, Ph.D. (International Medical Translation Service Inc., Osaka, Japan) for medical writing assistance.

Funding

The study was supported by study funds from JSPS KAKENHI (19K16989, 22K15693, and 24K10606) to TT and the Keio University Program for the Advancement of Next Generation Research Projects to JN.

Author information

Author notes

  1. Tsubasa Takizawa and Keiko Ihara contributed equally as co-first authors.

  2. Koichi Fukunaga and Jin Nakahara contributed equally as co-senior authors.

Authors and Affiliations

  1. Department of Neurology, Keio University School of Medicine, Tokyo, 160-8582, Japan

    Tsubasa Takizawa, Keiko Ihara, Miyuki Unekawa, Chisato Iba, Narumi Watanabe, Yoshikane Izawa & Jin Nakahara

  2. Japanese Red Cross Ashikaga Hospital, Tochigi, Japan

    Keiko Ihara

  3. Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan

    Shizuko Kagawa, Shingo Nakayama, Kaori Sakurai, Shotaro Chubachi & Koichi Fukunaga

  4. Clinical and Translational Research Center, Keio University Hospital, Tokyo, Japan

    Naoki Miyazaki, Noriyuki Ishida & Ryo Takemura

  5. Department of Neurology, Tokyo Dental College Ichikawa General Hospital, Chiba, Japan

    Mamoru Shibata

Authors
  1. Tsubasa Takizawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Keiko Ihara
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Miyuki Unekawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Chisato Iba
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shizuko Kagawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Narumi Watanabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Shingo Nakayama
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Kaori Sakurai
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Naoki Miyazaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Noriyuki Ishida
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Ryo Takemura
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Mamoru Shibata
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Yoshikane Izawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Shotaro Chubachi
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Koichi Fukunaga
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Jin Nakahara
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

TT conceptualized the study. TT, SC, and KF designed the work. MU, SK, CI, TT, and NW were involved in data acquisition. MU, TT, NM, NI, and RT analyzed the data. All authors (especially TT, KI, MU, and SC) interpreted the data. KI, TT, and MU drafted the manuscript. All authors revised the manuscript for intellectual content. JN and KF supervised the research. All authors have read and approved the final manuscript.

Corresponding author

Correspondence to Tsubasa Takizawa.

Ethics declarations

Ethics approval and consent to participate

All experimental procedures were approved by the Keio University Institutional Animal Care and Use Committee (authorizations #A2022-257 and A2021-006). All procedures were performed in accordance with university guidelines and Animal Research: Reporting of In Vivo Experiments (ARRIVE) reporting guidelines for the care and use of laboratory animals.

Consent for publication

Not applicable.

Competing interests

The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: TT is a consultant/advisor and/or serves on an advisory board for Eli Lilly, Otsuka, Amgen, Pfizer, and Teijin and has received speaker honoraria from Eli Lilly, Daiichi Sankyo, Otsuka, Amgen, Kowa, Kyowa Kirin, Eisai, UCB Japan, Takeda, and Santen Pharmaceutical and grant/funding from Eli Lilly, Pfizer, and Tsumura outside the submitted work. JN has received honoraria and research scholarships from Amgen, Novartis, and Daiichi Sankyo.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Takizawa, T., Ihara, K., Unekawa, M. et al. Effects of passive smoking on cortical spreading depolarization in male and female mice. J Headache Pain 25, 162 (2024). https://doi.org/10.1186/s10194-024-01867-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s10194-024-01867-3

Keywords

The Journal of Headache and Pain

ISSN: 1129-2377

Contact us